APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. Its electrophysiology products consist of electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and multi-channel electrophysiology systems. The company's coronary access products are composed of guide wires, microcatheters, balloons, and contrast guide wires and catheters. Its peripheral vascular intervention products include microcatheters, peripheral adjustable valve catheter sheath, contrast catheters, and contrast guide wires. The company also manages original equipment manufacturer business providing various types of vascular and non-vascular delivery systems, catheters, guide wires, and nickel-titanium products. APT Medical was founded by Zheng Hui Cheng on June 17, 2002 and is headquartered in Shenzhen, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company